Last reviewed · How we verify
NCT07046624
Prevention of Phlebitis, Infiltration and Extravasation With Infusion Monitoring System
NA trial testing Infusion monitoring system developed for use by nurses in patient care in Extravasation in 102 participants. Not yet recruiting.
8 June 2026
Quick facts
| Lead sponsor | Ordu University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 102 |
| Start date | 8 November 2025 |
| Primary completion | 8 June 2026 |
| Estimated completion | 8 July 2026 |
Drugs / interventions tested
- Infusion monitoring system developed for use by nurses in patient care
Conditions studied
- Extravasation — all drugs for Extravasation →
- Intensive Care Units (ICUs) — all drugs for Intensive Care Units (ICUs) →
- Phlebitis — all drugs for Phlebitis →
- Infiltration — all drugs for Infiltration →
Sponsor
Ordu University
Who can join
18 and older, any sex, with Extravasation or Intensive Care Units (ICUs). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Peripheral venous catheter complications are conditions that are frequently seen in intensive care clinics and require nursing care. The most common complications are phlebitis, infiltration and extravasation. Nurses should take the necessary precautions to prevent these complications from developing.. Therefore, this planned thesis study aims to establish an infusion monitoring system and evaluate its effectiveness in early detection of complications related to peripheral intravenous catheters. The research is planned as a randomized controlled experimental study. The study will be conducted in Ordu State Hospital General Intensive Care Unit 1 and General Intensive Care Unit 3 clinics. The universe of the study will consist of patients receiving inpatient treatment in General Intensive Care Unit 1 and General Intensive Care Unit 3 clinics. The sample size will be determined by g-power analysis after a two-month preliminary follow-up. Data will be collected with the "Clinical Follow-up Form", "Patient Information Form", and "Complication Follow-up Form". The clinics included in the study will be divided into two groups as experimental and control groups. First, the frequency of complications will be determined in the experimental and control groups. Then, while the control group continues its routine protocol and applications, an infusion follow-up system will be developed in the experimental group and will be used by nurses in patient care. In the final stage, the frequency of peripheral venous catheter complications will be determined again. Data will be evaluated using the SPSS 22.0 package program at a significance level of p\<0.05 and a confidence interval of 95%.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07046624
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ordu University trials
Trials by the same sponsor.
- NCT07527676 — Hypoglycemia Fear Affect Autonomic Function, Physical Activity, and Exercise Capacity in Type I Diabetes · not yet recruiting
- NCT07504874 — The Effect of Gardening Activities on the Quality of Life of Students With Mild Intellectual Disability · NA · not yet recruiting
- NCT07500402 — THE EFFECT OF GARDENING ON PSYCHOLOGICAL WELL-BEING AND CARE AMONG NURSING HOME CARE STAFF · NA · not yet recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT07457268 — Effect of Transcutaneous Auricular Trigeminal Nerve Stimulation on Migraine · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07046624 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ordu University
- Last refreshed: 17 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07046624.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing